ISMRM 25th Annual Meeting & Exhibition • 22-27 April 2017 • Honolulu, HI, USA
Plenary Session: Gadolinium Deposition
ORGANIZERS: Peter Caravan, Ph.D. & Winfried Willinek, M.D.
Monday, 24 April 2017
Slack Channel: #plenary
Session Number: P01
This plenary session will address increased concerns about Gadolinium (Gd) deposition and Gd-associated toxicity have impacted how Gadolinium is currently used. This plenary session will examine the state of the art with respect to toxicity and tissue deposition, and how this depends on the specific contrast agent. Perspectives on how recent concerns about Gd are impacting practice around the world will be discussed.
Upon completion of this course, participants should be able to:
-Summarize the history of Gadolinium contrast development;
-Illustrate NSF and Gadolinium deposition;
-Analyze the link between chemical structure and toxicity/deposition;
-Evaluate alternatives available and under development;
-Discuss the European perspective on how practice is impacted including whether Gadolinium can and should be avoided as well as liability and patient concerns; and
-Explain the Asian and North American perspectives on how practice is impacted including whether Gadolinium can and should be avoided as well as liability and patient concerns.
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for